The Domestic And International Environment For The Development Of Active Pharmaceutical Ingredients

China is a major producer of active pharmaceutical ingredients, with a production of 1.36 million tons in 2012, a year-on-year increase of 9.05%, ranking first in the world in terms of production. The achievement of economies of scale benefits from China's low production costs and environmental pollution. In the current situation where prices are generally rising and environmental management is constantly strengthening, the cost advantage of industry development has become less apparent.
Internationally, China's biggest competitor India, although not as large in terms of industry development scale as China, has significant advantages in cost advantage and industry development speed compared to China.